Xiaoqinglong granules + seretide

Xiaoqinglong granules + seretide is a combination therapy used primarily as an add-on treatment for asthma. Xiaoqinglong granules (XQLG) are a traditional Chinese medicine formulation containing multiple herbal ingredients, including Herb Ephedrae, Ramulus Cinnamomi, Rhizoma Zingiberis, Radix Asari, Fructus Schisandrae, and Radix Paeoniae Alba. The main active compounds identified in XQLG include ephedrine hydrochloride and paeoniflorin. Seretide is a fixed-dose combination inhaler containing fluticasone propionate (an inhaled corticosteroid) and salmeterol xinafoate (a long-acting beta-2 adrenergic agonist). The mechanism of action for this combination involves anti-inflammatory effects from fluticasone propionate and bronchodilation from salmeterol; XQLG may provide additional symptom relief in patients with specific traditional Chinese medicine-defined symptoms. This combination has been studied as an adjunctive therapy in adult patients with mild-to-moderate persistent asthma who are already receiving standard inhaled corticosteroid/long-acting beta agonist therapy[1][2][3][4].

Other names

Xiaoqinglong Keli + seretide